The NASDAQ OMX Group (Nasdaq:NDAQ) reported first quarter 2008 net income of $121.4 million, or $0.69 per diluted share, an increase of $103.1 million from $18.3 million, or $0.14 per diluted share, in the first quarter of 2007.

At the end of the settlement date of April 30, 2008, short interest in 2,653 NASDAQ Global Market securities totaled 9,427,457,178 shares compared with 9,420,702,070 shares in 2,680 Global Market issues reported for the prior settlement date of April 15, 2008. The end-of-April short interest represents 4.86 days average daily NASDAQ Global Market share volume for the reporting period, compared with 4.92 days for the prior reporting period.

The NASDAQ OMX Group, Inc. ("NASDAQ") (Nasdaq:NDAQ) announced today the results of the semi-annual re-ranking of the NASDAQ Biotechnology Index(r) (Nasdaq:NBI), which will become effective with the market open on Monday, May 19, 2008.

At the end of the settlement date of April 15, 2008, short interest in 2,680 NASDAQ Global Market(SM) securities totaled 9,420,702,070 shares compared with 9,480,978,979 shares in 2,688 Global Market issues reported for the prior settlement date of March 31, 2008. The mid-April short interest represents 4.92 days average daily NASDAQ Global Market share volume for the reporting period, compared with 3.97 days for the prior reporting period.

The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced consolidated market performance statistics for its U.S. and Nordic exchanges for the month of March 2008.

TRM Corporation (Nasdaq: TRMM) today announced its plans to withdraw its request for hearing and have its shares of common stock delisted from the NASDAQ Global Market.

The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced today that it has filed its application with the UK Financial Services Authority (FSA) for the NASDAQ OMX Pan European Market to become a multilateral trading facility (MTF).

The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) and Millennium India Acquisition Company, Inc. (AMEX:MQC) announced that its Board of Directors has approved the decision to switch the listing of its common stock from the American Stock Exchange to The NASDAQ OMX Group, Inc. effective, April 15th, 2008. The company now trades under the ticker symbol (Nasdaq:SMCG) and marks the 17th AMEX switch to NASDAQ OMX this year.

The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced that The NASDAQ Stock Market(r) (NASDAQ(r)) attracted more initial public offerings (IPOs) in the first quarter of 2008 than any other U.S. exchange.

DARA BioSciences (Nasdaq: DARA) announced today that the audit report accompanying the financial statements for the fiscal year ended December 31, 2007, as included in the Company's Annual Report on 10-K filed on March 31, 2008, contained a going concern qualification.

The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced that The NASDAQ Stock Market has listed two new exchange-traded funds (ETFs) sponsored by Barclays Global Investors, N.A. (BGI) -- the world's largest ETF provider. NASDAQ is the most liquid U.S. market for ETFs, capturing 39.0% of all U.S. ETF volume in February. Matched volume was 8.1 billion, more than any other U.S. exchange.

The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced today the introduction of the NASDAQ OMX 100 Index(sm) (Nasdaq:QOMX), a new global benchmark for the NASDAQ OMX Group.